Matthew M. Walsh - 31 Mar 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Financial Officer
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Matthew M. Walsh
Issuer symbol
OGN
Transactions as of
31 Mar 2024
Net transactions value
-$183,338
Form type
4
Filing time
03 Apr 2024, 18:42:08 UTC
Previous filing
02 Apr 2024
Next filing
07 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +7,753 +10% $0.000000 81,815 31 Mar 2024 Direct
transaction OGN Common Stock Tax liability $71,797 -3,819 -4.7% $18.80 77,996 31 Mar 2024 Direct
transaction OGN Common Stock Options Exercise $0 +12,046 +15% $0.000000 90,042 31 Mar 2024 Direct
transaction OGN Common Stock Tax liability $111,540 -5,933 -6.6% $18.80 84,109 31 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -7,753 -50% $0.000000 7,754 31 Mar 2024 Common Stock 7,753 Direct F1, F2
transaction OGN Restricted Stock Units Options Exercise $0 -12,046 -33% $0.000000 24,093 31 Mar 2024 Common Stock 12,046 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock.
F2 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025.
F3 On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026.